Advertisement

Analytical and Bioanalytical Chemistry

, Volume 388, Issue 7, pp 1467–1474 | Cite as

Bioanalytical procedures for detection of chemical agents in hair in the case of drug-facilitated crimes

  • Pascal Kintz
Review

Abstract

The use of a drug to modify a person’s behavior for criminal gain is not a recent phenomenon. However, the recent increase in reports of drug-facilitated crimes (sexual assault, robbery) has caused alarm in the general public. The drugs involved can be pharmaceuticals, such as benzodiazepines (flunitrazepam, lorazepam, etc.), hypnotics (zopiclone, zolpidem), sedatives (neuroleptics, some anti-H1) or anaesthetics (γ-hydroxybutyrate, ketamine), drugs of abuse, such as cannabis, ecstasy or LSD, or more often ethanol. To perform successful toxicological examinations, the analyst must follow some important rules: (1) obtain as soon as possible the corresponding biological specimens (blood and urine); (2) collect hair about 1 month after the alleged event; (3) use sophisticated analytical techniques (gas or liquid chromatography coupled to tandem mass spectrometry, MS/MS, headspace gas chromatography); and (4) take care in the interpretation of the findings. Drugs used to facilitate sexual assaults can be difficult to detect (active products at low doses, chemical instability), possess amnesic properties and can be rapidly cleared from the body (short half-life). In these situations, blood or even urine can be of low interest. This is the reason why some laboratories have developed an original approach based on hair testing. Hair was suggested as a valuable specimen in situations where, as a result of a delay in reporting the crime, natural processes have eliminated the drug from typical biological specimens. While there are a lot of papers that have focused on the identification of drugs in hair following chronic drug use, those dealing with a single dose are very scarce. The experience of the author and a review of the existing literature will be presented for cases involving benzodiazepines, hypnotics, γ-hydroxybutyrate and various sedatives or chemical weapons. The expected concentrations in hair are in the low picogram/milligram range for most compounds. Hair analysis may be a useful adjunct to conventional drug testing in sexual assault. It should not be considered as an alternative to blood and urine analyses, but as a complement. This approach may find useful applications, but the definition of legally defensible cutoff values would require much more data. MS/MS technologies appear as a prerequisite in drug-facilitated cases.

Keywords

Hair Drug-facilitated crime Drug-facilitated sexual assault Liquid chromatography–mass spectrometry 

References

  1. 1.
    Wells D (2001) Sci Justice 41:197–199CrossRefGoogle Scholar
  2. 2.
    Hindmarch I, ElSohly M, Gambles J et al (2001) J Clin Forensic Med 8:197–205CrossRefGoogle Scholar
  3. 3.
    LeBeau M, Andollo W, Hearn WL et al (1999) J Forensic Sci 44:227–230Google Scholar
  4. 4.
    Kintz P, Cirimele V, Goullé JP, Ludes B (2001) Clin Chem 47:2033–2034Google Scholar
  5. 5.
    Verstraete A (2002) Ann Toxicol Anal 14:390–394Google Scholar
  6. 6.
    Goullé JP, Chèze M, Pépin G (2003) J Anal Toxicol 27:574–580Google Scholar
  7. 7.
    Kintz P, Cirimele V, Jamey C, Ludes B (2003) J Forensic Sci 48:195–200Google Scholar
  8. 8.
    Shen M, Liu XQ, Liu W, Xiang P, Shen B (2006) Fa Xi Xue Za Zhi 22:48–51Google Scholar
  9. 9.
    Laloup M, Ramirez Fernandez M, De Boeck G, Wood M, Maes V, Samyn N (2005) J Anal Toxicol 29:616–626Google Scholar
  10. 10.
    Villain M, Concheiro M, Cirimele V, Kintz P (2005) J Chromatogr B 825:72–78CrossRefGoogle Scholar
  11. 11.
    Villain M, Chèze M, Dumestre V, Ludes B, Kintz P (2004) J Anal Toxicol 28:516–519Google Scholar
  12. 12.
    Kintz P, Villain M, Dumestre-Toulet V, Ludes B (2005) J Clin Forensic Med 12:36–41CrossRefGoogle Scholar
  13. 13.
    Villain M, Chèze M, Tracqui A, Ludes B, Kintz P (2004) Forensic Sci Int 143:157–161CrossRefGoogle Scholar
  14. 14.
    Villain M, Chèze M, Ludes B, Kintz P (2004) Forensic Sci Int 145:117–121CrossRefGoogle Scholar
  15. 15.
    Kintz P, Villain M, Chèze M, Pépin G (2005) Forensic Sci Int 153:222–226CrossRefGoogle Scholar
  16. 16.
    Kintz P, Villain M, Cirimèle V, Pépin G, Ludes B (2004) Forensic Sci Int 145:131–135CrossRefGoogle Scholar
  17. 17.
    Chèze M, Villain M, Pépin G (2004) Forensic Sci Int 145:123–130CrossRefGoogle Scholar
  18. 18.
    Frison G, Favretto D, Tedeschi L, Ferrara SD (2003) Forensic Sci Int 133:171–174CrossRefGoogle Scholar
  19. 19.
    Villain M, Tournoud C, Flesch F, Cirimele V, Kintz P (2006) J Chromatogr B 842:111–115CrossRefGoogle Scholar
  20. 20.
    Bartsch C, Risse M, Schütz H, Weigand N, Weiler G (2003) Forensic Sci Int 137:147–151CrossRefGoogle Scholar
  21. 21.
    Sporkert F, Augsburger M, Brandt-Casadevall C, Mangin P (2005) Ann Toxicol Anal 17:127Google Scholar
  22. 22.
    Pépin G, Chèze M, Duffort G, Vayssette F (2002) Ann Toxicol Anal 14:395–406CrossRefGoogle Scholar
  23. 23.
    Kintz P, Villain M, Pujol ML, Salquebre G, Cirimele V (2006) In: Society of Forensic Toxicologists annual meeting, AustinGoogle Scholar
  24. 24.
    Kintz P, Villain M, Cirimele V (2006) J Anal Toxicol 30:400–402Google Scholar
  25. 25.
    Kintz P, Evans J, Villain M, Cirimele V (2007) Forensic Sci Int (in press)Google Scholar
  26. 26.
    Kintz P, Villain M, Cirimele V (2006) Ther Drug Monit 28:442–446CrossRefGoogle Scholar
  27. 27.
    Cheze M, Duffort G, Deveaux M, Pépin G (2005) Forensic Sci Int 153:3–10CrossRefGoogle Scholar
  28. 28.
    Negrusz A, Gaensslen RE (2003) Anal Bioanal Chem 376:1192–1197CrossRefGoogle Scholar
  29. 29.
    Saint-Martin P, Furet Y, O’Byrne P, Bouyssy M, Paintaud G, Autret-Leca E (2006) Thérapie 61:145–150CrossRefGoogle Scholar
  30. 30.
    Pragst F, Balikova MA (2006) Clin Chim Acta 370:17–49CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  1. 1.Laboratoire ChemToxIllkirchFrance

Personalised recommendations